Oculis Holding AG (OCS) Operating Income (2022 - 2026)
Oculis Holding AG (OCS) recorded Operating Income of $392,224 in Q2 2026, up 24.4% from $315,259 a year earlier and up 47.0% from the prior quarter.
Oculis Holding AG (OCS) Operating Income (2022 - 2026) Analysis & Trends
On a TTM basis, Oculis Holding AG's Operating Income came in at $1.48 million as of Jun 30, 2026, up 66.9% year-over-year; for FY2025, it was $1.5 million, up 92.4% from FY2024.
- Annual Operating Income has a five-year compound annual growth rate of 7.2% (FY2020 to FY2025).
- Across earlier years, Operating Income came in at $779,777 in FY2024 (-21.7%), $995,454 in FY2023 (+4.1%), $956,035 in FY2022 (-9.0%) and $1.05 million in FY2021 (-0.8%).
- Quarterly Operating Income has ranged from $3,425 in Q4 2024 to $514,231 in Q4 2025 over the past five years.
- On a year-over-year basis, Operating Income rose in five of the last seven quarters, with an average decline of 3.8%.
- Peak year-over-year performance for Operating Income in the last five years was growth of 24.6% in Q1 2025, against a decline of 98.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $266,894 (Q1 2026), $514,231 (Q4 2025) and $303,777 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Oculis Holding AG | 410.37 Mn | -601.10 Mn | - | 392,224.12 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 392,224.12 |
| Mar 31, 2026 | 266,893.98 |
| Dec 31, 2025 | 514,230.78 |
| Sep 30, 2025 | 303,776.61 |
| Jun 30, 2025 | 315,259.35 |
| Mar 31, 2025 | 316,991.40 |
| Dec 31, 2024 | 3,424.57 |
| Sep 30, 2024 | 249,308.76 |
| Jun 30, 2024 | 270,919.40 |
| Mar 31, 2024 | 254,341.47 |
| Dec 31, 2023 | 208,560.58 |
| Sep 30, 2023 | 247,941.41 |
| Jun 30, 2023 | 278,043.89 |
| Mar 31, 2023 | 247,586.23 |
| Dec 31, 2022 | 222,136.69 |
| Sep 30, 2022 | 209,162.24 |
| Jun 30, 2022 | 265,803.01 |
Oculis Holding AG Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=OCS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();